This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pires Das Neves, R. N. Articles by Pereira, M. D. L. Search for Related Content PubMed PubMed Citation Articles by Pires Das Neves, R. N. Articles by Pereira, M. D. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Antioxidants Arsenic Hazardous Substances DB ARSENIC COMPOUNDS SODIUM ARSENITE Social Bookmarking                         What's this?

Protective Activity of Hesperidin and Lipoic Acid Against Sodium Arsenite Acute Toxicity in Mice

CICECO, Department of Biology, Campus de Santiago, University of Aveiro, 3810-193 Aveiro, Portugal

Félix Carvalho

REQUIMTE, Toxicology Department, Faculty of Pharmacy, University of Porto, 4099-033 Porto, Portugal

Márcia Carvalho

REQUIMTE, Toxicology Department, Faculty of Pharmacy, University of Porto, 4099-033 Porto, Portugal

Eduarda Fernandes

REQUIMTE, Toxicology Department, Faculty of Pharmacy, University of Porto, 4099-033 Porto, Portugal

Elisa Soares

REQUIMTE, Toxicology Department, Faculty of Pharmacy, University of Porto, 4099-033 Porto, Portugal

Maria De Lourdes Bastos

REQUIMTE, Toxicology Department, Faculty of Pharmacy, University of Porto, 4099-033 Porto, Portugal

Maria De Lourdes Pereira

CICECO, Department of Biology, Campus de Santiago, University of Aveiro, 3810-193 Aveiro, Portugal, lpereira{at}bio.ua.pt

The objective of the present work was to evaluate the toxic effects of sodium arsenite, As(III), in mice and the protective effect of 2 antioxidants, hesperidin and lipoic acid, against the observed As(III)-induced toxicity. In each study, mice were assigned to 1 of 4 groups: control, antioxidant, antioxidant + arsenite, and arsenite. Animals were first injected with the vehicle or 25 mg antioxidant/kg BW. After 30 minutes they received an injection of 10 mg arsenite/kg BW or 0.9% NaCl. Two hours after the first injection, the liver, kidney, and testis were collected for histological evaluation. Liver samples were also taken for quantification of arsenic. In mice exposed only to As(III), various histopathological effects were observed in the liver, kidneys, and testes. In mice pretreated with either hesperidin or lipoic acid, a reduction of histopathologic effects on the liver and kidneys was observed. No protective effects were observed in the testes for either of the 2 studied antioxidants. In conclusion, hesperidin and lipoic acid provided protective effects against As(III)-induced acute toxicity in the liver and kidneys of mice. These compounds may potentially play an important role in the protection of populations chronically exposed to arsenic.

Key Words: Hesperidin • lipoic acid • sodium arsenite • histopathology • mice • liver • kidney • testis.

References

• Albores, A., Cebrian, M.E., Garcia-Vargas, G.G., Connelly, J.C., Price, S.C., Hinton, R.H., Bach, P.H., and Bridges, J.W. (1996). Enhanced arsenite-induced hepatic morphological and biochemical changes in phenobarbitalpretreated rats. Toxicol Pathol 24, 172—80.[Abstract/Free Full Text]
• Allegra, C., Bartolo, M. Jr., Carioti, B., and Cassiani, D. (1995). An original microhaemorheological approach to the pharmacological effects of Daflon 500 mg in severe chronic venous insufficiency. Int J Microcirc Clin Exp 15(Suppl 1), 50—4.[Web of Science][Medline] [Order article via Infotrieve]
• Amiel, M., and Barbe, R. (1998). Study of the pharmacodynamic activity of Daflon 500 mg. Ann Cardiol Angeiol (Paris) 47, 185—8.[Medline] [Order article via Infotrieve]
• Anderwald, C., Koca, G., Furnsinn, C., Waldausl, W., and Roden, M. (2002). Inhibition of glucose production and stimulation of bile flow by R(+)-alpha-lipoic acid enantiomer in rat liver. Liver 22(4), 355—62.[CrossRef][Medline] [Order article via Infotrieve]
• Aposhian, H.V. (1997). Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 37, 397—419.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Aposhian, H.V., Gurzau, E.S., Le, X.C., Gurzau, A., Healy, S.M., Lu, X., Ma, M., Yip, L., Zakharyan, R.A., Maiorino, R.M., Dart, R.C., Tircus, M.G., Gonzalez-Ramirez, D., Morgan, D.L., Avram, D., and Aposhian, M.M. (2000). Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13(8), 693—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Applegate, L.A., Luscher, P., and Tyrrell, R.M. (1991). Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res 51(3), 974—8.[Abstract/Free Full Text]
• Agency for Toxic Substances and Disease Registry (ATSDR) (2000). Toxicologic Profile for Arsenic (update). U.S. Department of Health & Human Services, Washington, D.C.
• Barchowsky, A., Klei, L.R., Dudek, E.J., Swartz, H.M., and James, P.E. (1999). Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic Biol Med 27, 1405—12.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bartolome, B., Cordoba, S., Nieto, S., Fernandez-Herrera, J., and Garcia-Diez, A. (1999). Acute arsenic poisoning: clinical andhistopathological features. Br J Dermatol 141(6), 1106—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Biewenga, G.P., Haenen, G.R., and Bast, A. (1997). The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 29(3), 315—31.[Web of Science][Medline] [Order article via Infotrieve]
• Bludovska, M., Kotyzova, D., Koutensky, J., and Eybl, V. (1999). The influence of alpha-lipoic acid on the toxicity of cadmium. Gen Physiol Biophys 18, 28—32.[Medline] [Order article via Infotrieve]
• Buchet, J.P., Lauwerys, R., and Roels, H. (1981). Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsonate in man. Int Arch Occup Environ Health 48, 71—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cebrian, M.E., Albores, A., Aguilar, M., and Blakely, E. (1983). Chronic arsenic poisoning in the north of Mexico. Hum Toxicol 2(1), 121—33.[Web of Science][Medline] [Order article via Infotrieve]
• Chen, A., Cao, E.H., Zhang, T.C., and Qin, J.F. (2002). Arsenite-induced reactive oxygen species and the repression of -tocoferol in the MGC-803 cells. Eur J Pharmacol 448, 11—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Csanaky, I., and Gregus, Z. (2002). Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites. Comp Biochem Physiol 131, 355—65.
• Cullen, W.R. (1989). The metabolism of methylarsine oxide and sulfide. Appl Organometal Chem 3, 71—8.[CrossRef]
• Ellenhorn, M.J. (1997). Arsenic. In Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning (M. J. Ellenhorn, ed.), pp. 1538—43. Williams & Wilkins, Baltimore.
• Ercal, N., Gurer-Orhan, H., and Aykin-Burns, N. (2001). Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 1, 529—39.[CrossRef][Medline] [Order article via Infotrieve]
• Fanton, L., Duperret, S., Guillaumee, F., Miras, A., Vallon, J.J., and Malicier, D. (1999). Fatal rhabdomyolysis in arsenic trioxide poisoning. Hum Exp Toxicol 18, 640—1.[Free Full Text]
• Flora, S.J., Dubey, R., Kannan, G.M., Chauhan, R.S., Pant, B.P., and Jaiswal, D.K. (2002). Meso 2,3-dimercaptosuccinic acid (DMSA) and monoisoamyl DMSA effect on gallium arsenide induced pathological liver injury in rats. Toxicol Lett 132, 9—17.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Flora, S.J., Pant, S.C., Malhotra, P.R., and Kannan, G.M. (1997). Biochemical and histopathological changes in arsenic-intoxicated rats coexposed to ethanol. Alcohol 14, 563—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Galati, E.M., Monforte, M.T., Kirjavainen, S., Forestieri, A.M., Trovato, A., and Tripodo, M.M. (1994). Biological effects of hesperidin, a citrus flavonoid. (Note I): antiinflammatory and analgesic activity. Farmaco 40(11), 709— 12.[Medline] [Order article via Infotrieve]
• Garg, A., Garg, S., Zaneveld, L.J., and Singla, A.K. (2001). Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 15(8), 655—69.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Goering, P.L., Aposhian, H.V., Mass, M.J., Cebrian, M., Beck, B.D., and Waalkes, M.P. (1999). The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci 49, 5—14.[Abstract/Free Full Text]
• Gregus, Z., Gyurasics, A., and Csanaky, I. (2000). Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats. Toxicol Sci 56, 18—25.[Abstract/Free Full Text]
• Guzzo, A., Karatzios, C., Diorio, C., and DuBow, M.S. (1994). Metallothionein-II and ferritin H mRNA levels are increased in arsenite-exposed HeLa cells. Biochem Biophys Res Commun 205(1), 590—5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Healy, S.M., Casarez, E.A., Ayala-Fierro, F., and Aposhian, H. (1998). Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice. Toxicol Appl Pharmacol 148, 65—70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hirata, M., Tanaka, A., Hisanaga, A., and Ishinishi, N. (1990). Effects of glutathione depletion on the acute nephrotoxic potential of arsenite and on the arsenic metabolism in the hamster. Toxicol Appl Pharmacol 106, 469—81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hirata, F., Toyoshima, S., Axelrod, J., and Waxdal, M.J. (1980). Phospholipid methylation: a biochemical signal modulating lymphocyte mitogenesis. Proc Natl Acad Sci USA 77(2), 862—5.[Abstract/Free Full Text]
• Huff, J., Chan, P., and Nyska, A. (2000). Is the human carcinogen arsenic carcinogenic to laboratory animals? Toxicol Sci 55, 17—23.[Free Full Text]
• Institute of Laboratory Animal Resources (ILAR) ( 1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
• Knowles, F.C., and Benson, A.A. (1983). The biochemistry of arsenic. Trends Biochem Sci 8, 178—80.[CrossRef][Web of Science]
• Lee, T.C., and Ho, I.C. (1995). Modulation of cellular antioxidant defence activities by sodium arsenite in human fibroblasts. Arch Toxicol 69, 498— 504.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lewis, D.R., Southwick, J.W., Ouellet-Hellstrom, R., Rench, J., and Calderon, R.L. (1999). Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 107(5), 359—65.[Web of Science][Medline] [Order article via Infotrieve]
• Liu, J., Liu, Y., Goyer, R.A., Achanzar, W., and Waalkes, M.P. (2000). Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol Sci 55, 460—7.[Abstract/Free Full Text]
• Liu, J., Liu, Y., Powell, D.A., Waalkes, M.P., and Klaassen, C.D. (2002). Multidrug-resistance mdr1a/1b double knockout mice are more sensitive than wild type mice to acute arsenic toxicity, with higher arsenic accumulation in tissues. Toxicology 170(1—2), 55—62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lodge, L., Handelman, G.J., Konishi, T., Matsugo, S., Mathur, V.V., and Packer, L. (1997). Natural sources of lipoic acid: determination of lipoyllysine released from protease-digested tissues by high performance liquid chromatography incorporating electrochemical detection. J Appl Nutr 49, 3—11.
• Malarkodi, K.P., Balachandar, A.V., and Varalakshmi, P. (2003). Protective effect of lipoic acid on adriamycin induced lipid peroxidation in rat kidney. Mol Cell Biochem 247(1—2), 9—13.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mandal, B.K., Ogra, Y., and Suzuki, K.T. (2001). Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 14(4), 371—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Marafante, E., Vahter, M., Norin, H., Envall, J., Sandström, M., Christakopoulos, A., and Ryhage, R. (1987). Biotransformation of dimethylarsinic acid in mouse, hamster and man. J Appl Toxicol 7, 111—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Maritim, A.C., Sanders, R.A., and Watkins, J.B. 3rd. (2003). Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 14(5), 288—94.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mervaala, E., Finckenberg, P., Lapatto, R., Muller, D.N., Park, J.K., Dechend, R., Ganten, D., Vapaatalo, H., and Luft, F.C. (2003). Lipoic acid supplementation prevents angiotensin II-induced renal injury. Kidney Int 64(2), 501—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Moini, H., Packer, L., and Saris, N.E. (2002a). Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 182(1), 84—90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Moini, H., Tirosh, O., Park, Y.C., Cho, K.J., and Packer, L. (2002b). R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch Biochem Biophys 397(2), 384—91.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• National Academy of Sciences (2001). Arsenic in Drinking Water. National Academy Press Washington, DC.
• Nordenson, I., and Beckman, L. (1991). Is the genotoxic effect of arsenic mediated by oxygen free radicals? Hum Hered 41, 71—3.[Web of Science][Medline] [Order article via Infotrieve]
• Packer, L., Witt, E.H., and Tritschler, H.J. (1995). alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19(2), 227—50.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pant, N., Kumar, R., Murthy, R.C., and Srivastava, S.P. (2001). Male reproductive effect of arsenic in mice. Biometals 14(2), 113—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Peraza, M.A., Ayala-Fierro, F., Barber, D.S., Casarez, E., and Rael, L.T. (1998). Effects of micronutrients on metal toxicity. Environ Health Perspect 106 (Suppl 1), 203—16.[Web of Science][Medline] [Order article via Infotrieve]
• Petrick, J.S., Ayala-Fierro, F., Cullen, W.R., Carter, D.E., and Aposhian, H.V. (2000). Monomethylarsonous acid (MMAIII) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 163, 203—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Petrick, J.S., Jagadish, B., Mash, E.A., and Aposhian, H.V. (2001). Monomethylarsonous acid (MMA III ) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol 14, 651—6.[Web of Science][Medline] [Order article via Infotrieve]
• Ramanathan, K., Shila, S., Kumaran, S., andPanneerselvam, C. (2003). Ascorbic acid and alpha-tocopherol as potent modulators on arsenic induced toxicity in mitochondria. J Nutr Biochem 14(7), 416—20.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Santra, A., Maiti, A., Das, S., Lahiri, S., Charkaborty, S.K., and Mazumder, D.N. (2000). Hepatic damage caused by chronic arsenic toxicity in experimental animals. Clinical Toxicol 38, 395—405.[CrossRef]
• Sarkar, M., Chaudhuri, G.R., Chattopadhyay, A., and Biswas, N.M. (2003). Effect of sodium arsenite on spermatogenesis, plasma gonadotrophins and testosterone in rats. Asian J Androl 5, 27—31.[Web of Science][Medline] [Order article via Infotrieve]
• Schinkel, A.H., Mayer, U., Wagenaar, E., Mol, C.A., van Deemter, L., Smit, J.J., van der Valk, M.A., Voordouw, A.C., Spits, H., van Tellingen, O., Zijlmans, J.M., Fibbe, W.E., and Borst, P. (1997). Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94(8), 4028—33.[Abstract/Free Full Text]
• Smith, A.H., Arroyo, A.P., Mazumder, D.N., Kosnett, M.J., Hernandez, A.L., Beeris, M., Smith, M.M., and Moore, L.E. (2000). Arsenic-induced skin lesions among Atacameno people in Northern Chile despite good nutrition and centuries of exposure. Environ Health Perspect 108(7), 617— 20.[Web of Science][Medline] [Order article via Infotrieve]
• Smith, A.H., Goycolea, M., Haque, R., and Biggs, M.L. (1998). Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 147(7), 660—9.[Abstract/Free Full Text]
• Soares, M.E., Bastos, M.L., and Ferreira, M. (1995). Determination of arsenic, cadmium and lead in porcine and bovine kidneys by electrothermal atomic absorption spectrometry. Analyst 120, 2367—70.[CrossRef][Medline] [Order article via Infotrieve]
• Styblo, M., Del Razo, L.M., Vega, L., Germolec, D.R., LeCluyse, E.L., Hamilton, G.A., Reed, W., Wang, C., Cullen, W.R., and Thomas, D.J. (2000). Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74, 289—99.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Takaoka, M., Ohkita, M., Kobayashi, Y., Yuba, M., and Matsumura, Y. (2002). Protective effect of alpha-lipoic acid against ischaemic acute renal failure in rats. Clin Exp Pharmacol Physiol 29(3), 189—94.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tseng, C.H. (2002). An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 53(5), 529—37.[Web of Science][Medline] [Order article via Infotrieve]
• Vahter, M., and Concha, G. (2001). Role of metabolism in arsenic toxicity. Pharmacol Toxicol 89, 1—5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Valentine, J.L., Cebrian, M.E., Garcia-Vargas, G.G., Faraji, B., Kuo, J., Gibb, H.J., and Lachenbruch, P.A. (1994). Daily selenium intake estimates for residents of arsenic-endemic areas. Environ Res 64(1), 1—9.[Medline] [Order article via Infotrieve]
• Wang, T.S., and Huang, H. (1994). Active oxygen species are involved in the induction of micronuclei by arsenite in XRS-5 cells. Mutagenesis 9, 253—7.[Abstract/Free Full Text]
• Wang, T.S., Kuo, C.F., Jan, K.Y., and Huang, H. (1996). Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J Cell Physiol 169, 256—68.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wu, M.M., Chiou, H.Y., Wang, T.W., Hsueh, Y.M., Wang, I.H., and Lee, T.C. (2001). Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern taiwan. Environ Health Perspect 109, 1011—7.[Web of Science][Medline] [Order article via Infotrieve]
• Yamanaka, K., Takabayashi, F., Mizoi, M., An, Y., Hasegawa, A., and Okada, S. (2001). Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. Biochem Biophys Res Commun 287, 66—70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Yamauchi, H., and Yamamura, Y. (1984). Metabolism and excretion of orally administered dimethylarsinic acid in the hamster. Toxicol Appl Pharmacol 74, 134—40.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Yamauchi, H., Yamato, N., and Yamamura, Y. (1988). Metabolism and excretion of orally and intraperitoneally administered methylarsonic acid in the hamster. Bull Environ Contam Toxicol 40, 280—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 32, No. 5, 527-535 (2004)
DOI: 10.1080/01926230490502566


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pires Das Neves, R. N. Articles by Pereira, M. D. L. Search for Related Content PubMed PubMed Citation Articles by Pires Das Neves, R. N. Articles by Pereira, M. D. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Antioxidants Arsenic Hazardous Substances DB ARSENIC COMPOUNDS SODIUM ARSENITE Social Bookmarking                         What's this?